Drug Pipeline

ITI-1284 20 mg Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
5
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
4
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06480383 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder Generalized Anxiety Disorder Recruiting
NCT06701903 Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder Generalized Anxiety Disorder Recruiting
NCT06651567 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation… Agitation Associated With Alzheimer's Dementia Recruiting
NCT06540833 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis… Psychosis Associated With Alzheimer's Disease Recruiting
Phase 1
NCT06299410 PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284… Healthy Volunteers Recruiting
Sponsors Running ITI-1284 20 mg Trials
Intra-Cellular Therapies, Inc. (5)
Disease Areas
Anxiety (2) Alzheimer's Disease (2) Dementia (1)
Get alerts when ITI-1284 20 mg trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free